Safety Study of F2695 SR in Major Depressive Disorder

Completed · Phase 3

Conditions studied: Major Depressive Disorder

In brief

The purpose of this study is to evaluate the long- term safety of F2695-SR in the treatment of adults with major depressive disorder.

Key facts

Study ID
NCT01034267
Run by
Forest Laboratories
People needed
828
Starts
2009-12-01
Last updated by the study team
2012-08-17

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.